U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07355504) titled 'Prostate Cancer Early Detection Using Serial MRI Examinations' on Dec. 19, 2025.
Brief Summary: The rationale of the PROCEDE trial is to explore a novel early detection strategy in which biopsy decision does not rely on one single MRI examination, but on the progression of the MRI lesion between 2 consecutive exams, with the objective of reducing the number of unnecessary biopsies, detection of non-clinically prostate cancer and, ultimately, overtreatment.
Study Start Date: Jan. 12
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer
Intervention:
PROCEDURE: MRI Examination
Patients randomized to the experimental arm will pr...